Details of the Drug Formulations

General Information of Drug (ID: DMPGUCF)

Drug Name
Dopamine Drug Info
Synonyms
Dopamin; Dopamina; Dopaminum; Dophamine; Hydroxytyramin; Hydroxytyramine; Intropin; LDP; Oxytyramine; Revimine; ASL 279; IP 498; Dopamina [INN-Spanish]; Dopamine (INN); Dopamine [INN:BAN]; Dopaminum [INN-Latin]; L-DOPAMINE; M-Hydroxytyramine hydrochloride; Medopa (TN); Intropin [*hydrochloride*]; KW-3-060; Beta-(3,4-Dihydroxyphenyl)ethylamine hydrochloride; Dopamine (USAN)(*hydrochloride*); A-(3,4-Dihydroxyphenyl)-b-aminoethane; Alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane; Pyrocatechol, 4-(2-aminoethyl)-(8CI); Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride; (3H)-Dopamine; 1,2-Benzenediol, 4-(2-aminoethyl)-(9CI); 1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride; 1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium; 153C5321-5FEE-4B0B-8925-F388F0EEEBD1; 2-(3,4-dihydroxyphenyl)ethylamine; 2-benzenediol; 3,4-Dihydroxyphenethylamine hydrochloride; 3,4-Dihydroxyphenylethylamine; 3,4-dihydroxyphenethylamine; 3-Hydroxtyramine; 3-Hydroxytyramine; 3-Hydroxytyramine Hydrobromide; 3-Hydroxytyramine hydrochloride; 4-(2-Aminoethyl)-1; 4-(2-Aminoethyl)-1,2-benzenediol; 4-(2-Aminoethyl)-1,2-bezenediol; 4-(2-Aminoethyl)benzene-1,2-diol; 4-(2-Aminoethyl)catechol; 4-(2-Aminoethyl)pyrocatechol; 4-(2-Aminoethyl)pyrocatechol hydrochloride; 4-(2-aminoethyl)-pyrocatechol
Indication
Disease Entry ICD 11 Status REF
Parkinson disease 8A00.0 Approved [1] , [2]
Hypotension BA20-BA21 Phase 1 [1] , [3]
Therapeutic Class
Cardiotonic Agents
Cross-matching ID
PubChem CID
681
ChEBI ID
CHEBI:18243
CAS Number
51-61-6
TTD ID
D0T7OW
VARIDT ID
DR00283
INTEDE ID
DR0532
ACDINA ID
D00212

Full List of Drug Formulations Containing This Drug

Dopamine 25-100 tablet
Company Formulation ID FDA Description
Bristol-Myers Squibb Company F06733 D&c yellow no. 10; Fd&c yellow no. 6; Magnesium stearate; Powdered cellulose
------------------------------------------------------------------------------------
Dopamine Hydrochloride 800 mcg/ml injectable
Company Formulation ID FDA Description
Baxter Healthcare Corporation F23433 Hydrochloric Acid; Sodium Bisulfite; Water; Dextrose Monohydrate
------------------------------------------------------------------------------------
Dopamine Hydrochloride 40mg/ml injectable
Company Formulation ID FDA Description
Hospira F23434 Sodium Metabisulfite; Anhydrous Citric Acid; Trisodium Citrate Dihydrate
------------------------------------------------------------------------------------
Dopamine Hydrochloride 6x injectable
Company Formulation ID FDA Description
Deseret Biologicals F23432 Demineralized Water; Ethanol
------------------------------------------------------------------------------------

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 940).
2 The pipeline and future of drug development in schizophrenia. Mol Psychiatry. 2007 Oct;12(10):904-22.
3 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015